1. (a) Except for a drug or device for which the U.S. Food and Drug Administration has issued a black box warning, the Program and the Maryland Children's Health Program may not apply a prior authorization requirement for a contraceptive drug or device that is:

   1. (1)

      1. (i) An intrauterine device; or
      2. (ii) An implantable rod;
   2. (2) Approved by the U.S. Food and Drug Administration; and
   3. (3) Obtained under a prescription written by an authorized prescriber.
2. (b) The Program and the Maryland Children's Health Program shall provide coverage for a single dispensing to an enrollee of a supply of prescription contraceptives for a 12-month period.

Added by Acts 2016, c. 436, § 1, eff. Jan. 1, 2018; Acts 2016, c. 437, § 1, eff. Jan. 1, 2018. Amended by Acts 2017, c. 820, § 1, eff. July 1, 2017; Acts 2017, c. 821, § 1, eff. July 1, 2017; Acts 2018, c. 464, § 1, eff. July 1, 2018; Acts 2018, c. 465, § 1, eff. July 1, 2018; Acts 2021, c. 757, § 1, eff. May 30, 2021; Acts 2021, c. 758, § 1, eff. May 30, 2021; Acts 2022, c. 719, § 1, eff. Oct. 1, 2022; Acts 2022, c. 720, § 1, eff. Oct. 1, 2022; Acts 2023, c. 300, § 1, eff. Oct. 1, 2023; Acts 2023, c. 301, § 1, eff. Oct. 1, 2023.